Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes

MSK1 regulates the transcription of IL-1ra in response to TLR activation in macrophages

(2009) Joanne Darragh et al.   BIOCHEMICAL JOURNAL

Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling

(2009) Yeonseok Chung et al.   IMMUNITY

Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role

(2009) Roland Liblau   JOURNAL OF THE NEUROLOGICAL SCIENCES

An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist

(2009) Ivona Aksentijevich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1  in human monocytes and multiple sclerosis

(2009) D. Burger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-1, IL-18, and IL-33 families of cytokines

(2008) William P. Arend et al.   IMMUNOLOGICAL REVIEWS

Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy

(2008) Martin A. Kriegel et al.   INTERNATIONAL IMMUNOLOGY

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

(2008) Daniel D Mikol et al.   LANCET NEUROLOGY

Differential regulation of cytokine production by PI3Kδ in human monocytes upon acute and chronic inflammatory conditions

(2008) Nicolas Molnarfi et al.   MOLECULAR IMMUNOLOGY